http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20060019264-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_717c792fca7cc9c290c9db33e8fe078b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-28
filingDate 2004-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eab3005e90a4216f697129630d5a42c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a41163a31dcb2d97168379aa3e6b11ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97474a5243f0749df2e822c2c859f32d
publicationDate 2006-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20060019264-A
titleOfInvention Composition for preventing and treating intercellular information transmission inhibition through gap binding comprising selenocysteine or selenomethionine
abstract The present invention relates to a composition for preventing and treating intercellular information transmission inhibition through gap binding comprising selenocysteine or selenomethionine. In particular, the present invention prevents and recovers intercellular information transmission through gap binding and at the same time comprises a composition comprising at least one selenoamino acid selected from the group consisting of selenocysteine and selenomethionine, which are harmless to cells. In addition, the composition is not only applicable to the prophylaxis and treatment of diseases caused by the imbalance of intercellular information transmission through gap binding, but also to improve the pharmacological effect of the drug by using in combination with the existing drug. have.n n n n Selenocysteine, Selenomethionine, Intercellular Communication Through Gap Binding
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113201570-A
priorityDate 2004-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6398619
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45266674
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419593180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4766
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1090
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57473102
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553757
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419587092
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72277
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5746
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID105024
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448490712
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419584777
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415061053
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25076
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161368
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419565317
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20835957
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552441
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426100952
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554071
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553254
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65064
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406976611
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID544
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426285808

Total number of triples: 43.